AKT1 and osteosarcoma: Moreover, VEGF can act in an autocrine manner on several cancer cells, including aggressive osteosarcoma phenotypes, which leads to activation of various signaling pathways in these cells (e.g., PI3K/Akt and MEK/ERK), ultimately supporting tumor growth [63].